Log In
Print
BCIQ
Print
Print this Print this
 

MTKi-327 (BGB-102)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionMacrocyclic multi-targeted kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

BeiGene Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today